Share
226 Posts.
lightbulb Created with Sketch. 27
clock Created with Sketch. 28/06/21
13:44
Share
Originally posted by Silverchair:
↑
I believe PigsMightFly is recommending Clinuvel Pharmaceuticals as a SCREAMING BUY. Pigs spent most of the weekend making multiple comments on Afterpay and some obscure concrete mob that he doesn't hold and recommending to Sell them. But with CUV I think he has found a winner. On the 23/06 Pigs commented that the Clinuvel STROKE program has a realistic 10% chance of SUCCESS. It is the UNTREATED 85% that CUV is targeting with their ALREADY FDA, TGA and EMA approved drug . The very SAFE drug. Approval in STROKE will instantly add about $10 BILLION to the share price in my opinion (conservative). Now remember that CUV is already undervalued compared to just about any other Biotech on the ASX despite it having superior financial fundamentals and only treating the 'proof of concept' disease EPP. multiple chances at hitting the jackpot
Expand
Always appreciate your posts and knowledge on this wonderful company. I wouldn’t even bother replying to pigs. It’s obvious he has no idea about the company and or just stock bashing. You don’t need to justify anything to him. I’m sure most of the people on this forum know who to listen to.
(20min delay)